‌

US Patent 9550002 Phospholipid analogs as diapeutic agents and methods thereof

Patent 9550002 was granted and assigned to Cellectar on January, 2017 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Cellectar

Current Assignee

Cellectar

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

95500020

Patent Inventor Names

Marc Longino0

Anatoly Pinchuk0

Jamey P. Weichert0

Date of Patent

January 24, 2017

Patent Application Number

145013730

Date Filed

September 30, 2014

Patent Primary Examiner

‌

D. L. Jones

Patent abstract

The present invention provides methods and uses of phospholipid ether analogs as diagnostic and therapeutic agents for numerous cancers.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9550002 Phospholipid analogs as diapeutic agents and methods thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API